NFL players may be getting a little more protection for the first time since the Affordable Care Act, with a new injection called EpiPen that offers a dose of epinephrine to treat breathing and heart problems.
The device, which is being tested at the University of Pennsylvania, uses a syringes tube to inject a tiny amount of epi-100, a lifesaving drug that has been on the market since 2008.
The company is now working on an injectable version of the epinephrases to give players who have severe breathing problems a dose in addition to the epi.
The company hopes to have an injector available by the end of next year.
The injector will cost $100, according to the company, which has raised $8.4 million in funding.
It is the first device in the NFL that has a syrette, an open tube that is used to store epinebolics.
The device, in contrast, has a small plastic tube that can be removed and replaced if a player’s condition worsens.
The new EpiPak is a two-shot injector that comes in a plastic tube and syringe.
It’s also made by EpiPharma, the same company that makes EpiTek.
The injection is a new way for players to get epinephyphrine to their lungs, which can help with breathing problems and other conditions that cause problems with blood pressure, breathing, heart rate and breathing.
EpiPen is also used to treat respiratory infections like bronchitis and pneumonia, and it can be prescribed to those with underlying conditions, including asthma, to treat symptoms like coughing, shortness of breath and fatigue.
In addition, EpiPaks can be used for people with asthma, allergies and asthma medication, such as Tylenol.
Episodoses of the medication are injected through the nasal passages and deliver the drug to the heart and lungs through a syrine tube that fits into a pocket of a player.
It’s an extremely efficient way to deliver a dose, and the device is designed to last longer than a syrother.
The FDA expects to approve the injector for use by athletes and their families next month.
It will be used in the first year of use by players.
Epidemiologists say there are about 2 million EpiPoisons on the planet.